Vident Advisory’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$497K Buy
15,033
+1,900
+14% +$80.4K ﹤0.01% 1260
2025
Q4
$608K Sell
13,133
-2,333
-15% -$97.6K 0.01% 1056
2025
Q3
$541K Buy
15,466
+281
+2% +$9.77K 0.01% 1168
2025
Q2
$449K Sell
15,185
-791
-5% -$22.6K 0.01% 1122
2025
Q1
$477K Sell
15,976
-922
-5% -$28.2K 0.01% 1059
2024
Q4
$484K Buy
16,898
+3,672
+28% +$122K 0.01% 969
2024
Q3
$511K Sell
13,226
-2,055
-13% -$73.3K 0.01% 908
2024
Q2
$492K Buy
15,281
+7,671
+101% +$266K 0.01% 887
2024
Q1
$295K Sell
7,610
-145
-2% -$5.07K 0.01% 1030
2023
Q4
$239K Buy
+7,755
New +$194K 0.01% 1128

Other funds holding COLL